Clinical trial
The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study
NCT04943172 · Hancock Jaffe Laboratiores, Inc, Other · Active, not recruiting
Key facts
| NCT number | NCT04943172 |
|---|---|
| Title | The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study |
| Official title | The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis (SAVVE) Study |
| Acronym | SAVVE |
| Lead sponsor | Hancock Jaffe Laboratiores, Inc, Other |
| Collaborators | AXIOM Real Time Metrics Syntactx |
| Status | Active, not recruiting |
| Study type | Interventional |
| Conditions | Deep Venous Insufficiency (Diagnosis) |
| Intervention type | Device |
| Interventions | Hancock-Jaffe bioprosthetic venous valve (VenoValve®) |
| Enrollment | 75 |
| Start date | Aug 27, 2021 |
| Primary completion | Oct 18, 2024 |
| Completion | Mar 1, 2028 |
| First posted | Jun 29, 2021 |
| Last update posted | Feb 17, 2025 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: